Schonfeld Strategic Advisors’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19
Closed -$3.53K 2350
2024
Q1
$3.53K Sell
19
-3
-14% -$1.06K ﹤0.01% 1946
2023
Q4
$8.76K Sell
22
-2
-8% -$870 ﹤0.01% 1712
2023
Q3
$12.1K Sell
24
-1
-4% -$880 ﹤0.01% 1575
2023
Q2
$28.9K Hold
25
﹤0.01% 1863
2023
Q1
$27.1K Sell
25
-1
-4% -$1.22K ﹤0.01% 1816
2022
Q4
$28.3K Hold
26
﹤0.01% 2298
2022
Q3
$34K Buy
26
+1
+4% +$1.79K ﹤0.01% 2682
2022
Q2
$44K Hold
25
﹤0.01% 2239
2022
Q1
$108K Buy
+25
New +$97.7K ﹤0.01% 2210

Other funds holding ISPC

Schonfeld Strategic Advisors's ISPC Position: Q2 2024 in Review

Schonfeld Strategic Advisors sold out of iSpecimen (ISPC) in Q2 2024, closing a stake of 19 shares — an estimated $3.53K sold.

Schonfeld Strategic Advisors first reported a position in ISPC in Q1 2022 and held it in 9 quarters. The position peaked at $108K in Q1 2022. 11 funds tracked by Wall St. Rank hold ISPC as of Q2 2024.

  • Schonfeld Strategic Advisors reported no remaining iSpecimen position as of Q2 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 19 iSpecimen shares in Q2 2024, an estimated $3.53K.
  • Schonfeld Strategic Advisors first reported a position in iSpecimen in Q1 2022 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's iSpecimen position peaked at $108K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held iSpecimen as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.